USE OF DERIVATIVES OF SPIRONOLACTONE FOR THE INHIBITION OF THE PRO-FIBROGENIC ACTION OF HEPATIC STELLATE CELLS AND OF VASCULAR SMOOTH MUSCLE CELLS

Details for Australian Patent Application No. 2002319135 (hide)

International Classifications

Event Publications

16 January 2003 Complete Application Filed

Priority application(s): MI2001A000821 17.04.01 IT

17 April 2003 Application Open to Public Inspection

Published as AU-A-2002319135

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.